In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability

Small cell lung cancer (SCLC) is an aggressive disease, representing 15% of all cases of lung cancer, has high metastatic potential and low prognosis that urgently demands the development of novel therapeutic approaches. One of the proposed approaches has been the down-regulation of BCL2, with poorl...

Full description

Bibliographic Details
Main Authors: A.O. Santos, J.P. Pereira, M.C. Pedroso de Lima, S. Simões, J.N. Moreira
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2010-10-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001000013
_version_ 1818334819247980544
author A.O. Santos
J.P. Pereira
M.C. Pedroso de Lima
S. Simões
J.N. Moreira
author_facet A.O. Santos
J.P. Pereira
M.C. Pedroso de Lima
S. Simões
J.N. Moreira
author_sort A.O. Santos
collection DOAJ
description Small cell lung cancer (SCLC) is an aggressive disease, representing 15% of all cases of lung cancer, has high metastatic potential and low prognosis that urgently demands the development of novel therapeutic approaches. One of the proposed approaches has been the down-regulation of BCL2, with poorly clarified and controversial therapeutic value regarding SCLC. The use of anti-BCL2 small interfering RNA (siRNA) in SCLC has never been reported. The aim of the present study was to select and test the in vitro efficacy of anti-BCL2 siRNA sequences against the protein and mRNA levels of SCLC cells, and their effects on cytotoxicity and chemosensitization. Two anti-BCL2 siRNAs and the anti-BCL2 G3139 oligodeoxynucleotide (ODN) were evaluated in SCLC cells by the simultaneous determination of Bcl-2 and viability using a flow cytometry method recently developed by us in addition to Western blot, real-time reverse-transcription PCR, and cell growth after single and combined treatment with cisplatin. In contrast to previous reports about the use of ODN, a heterogeneous and up to 80% sequence-specific Bcl-2 protein knockdown was observed in the SW2, H2171 and H69 SCLC cell lines, although without significant sequence-specific reduction of cell viability, cell growth, or sensitization to cisplatin. Our results question previous data generated with antisense ODN and supporting the present concept of the therapeutic interest in BCL2 silencing per se in SCLC, and support the growing notion of the necessity of a multitargeting molecular approach for the treatment of cancer.
first_indexed 2024-12-13T14:13:35Z
format Article
id doaj.art-eac5f97ea45b4773a8b1a013f7a3acc4
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-13T14:13:35Z
publishDate 2010-10-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-eac5f97ea45b4773a8b1a013f7a3acc42022-12-21T23:42:24ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2010-10-01431010011009In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viabilityA.O. SantosJ.P. PereiraM.C. Pedroso de LimaS. SimõesJ.N. MoreiraSmall cell lung cancer (SCLC) is an aggressive disease, representing 15% of all cases of lung cancer, has high metastatic potential and low prognosis that urgently demands the development of novel therapeutic approaches. One of the proposed approaches has been the down-regulation of BCL2, with poorly clarified and controversial therapeutic value regarding SCLC. The use of anti-BCL2 small interfering RNA (siRNA) in SCLC has never been reported. The aim of the present study was to select and test the in vitro efficacy of anti-BCL2 siRNA sequences against the protein and mRNA levels of SCLC cells, and their effects on cytotoxicity and chemosensitization. Two anti-BCL2 siRNAs and the anti-BCL2 G3139 oligodeoxynucleotide (ODN) were evaluated in SCLC cells by the simultaneous determination of Bcl-2 and viability using a flow cytometry method recently developed by us in addition to Western blot, real-time reverse-transcription PCR, and cell growth after single and combined treatment with cisplatin. In contrast to previous reports about the use of ODN, a heterogeneous and up to 80% sequence-specific Bcl-2 protein knockdown was observed in the SW2, H2171 and H69 SCLC cell lines, although without significant sequence-specific reduction of cell viability, cell growth, or sensitization to cisplatin. Our results question previous data generated with antisense ODN and supporting the present concept of the therapeutic interest in BCL2 silencing per se in SCLC, and support the growing notion of the necessity of a multitargeting molecular approach for the treatment of cancer.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001000013Small cell lung cancerGene silencingBcl-2siRNAAntisense ODNFlow cytometryChemosensitization
spellingShingle A.O. Santos
J.P. Pereira
M.C. Pedroso de Lima
S. Simões
J.N. Moreira
In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability
Brazilian Journal of Medical and Biological Research
Small cell lung cancer
Gene silencing
Bcl-2
siRNA
Antisense ODN
Flow cytometry
Chemosensitization
title In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability
title_full In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability
title_fullStr In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability
title_full_unstemmed In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability
title_short In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability
title_sort in vitro modulation of bcl 2 levels in small cell lung cancer cells effects on cell viability
topic Small cell lung cancer
Gene silencing
Bcl-2
siRNA
Antisense ODN
Flow cytometry
Chemosensitization
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001000013
work_keys_str_mv AT aosantos invitromodulationofbcl2levelsinsmallcelllungcancercellseffectsoncellviability
AT jppereira invitromodulationofbcl2levelsinsmallcelllungcancercellseffectsoncellviability
AT mcpedrosodelima invitromodulationofbcl2levelsinsmallcelllungcancercellseffectsoncellviability
AT ssimoes invitromodulationofbcl2levelsinsmallcelllungcancercellseffectsoncellviability
AT jnmoreira invitromodulationofbcl2levelsinsmallcelllungcancercellseffectsoncellviability